Topic: How To Invest

What is Pat’s commentary for the week of June 21, 2022

Article Excerpt

The COVID-19 pandemic resulted in short-term disruptions to elective medical procedures over the past couple of years. To avoid potential COVID exposure, some patients put off procedures that were important but not urgent. Many hospitals cancelled elective procedures altogether. Even so, hospital-equipment supplier Steris went on up to a new peak of $255 a share in April. Since then, the stock has dropped along with the general market. However, the company is in a great position to profit from favourable long-term demographic trends, such as an aging population, and continuing advances in medical techniques. Meanwhile, a recent key acquisition has pole-vaulted Steris into a lucrative new market. I asked our Successful Investor research department to draw up this Inner Circle Spotlight report on the stock. It explains why we feel Steris has a great deal of appeal for investors seeking opportunities for conservative long-term growth. We hope you enjoy and profit from this Spotlight. Pat INNER CIRCLE SPOTLIGHT REPORT ON STERIS PLC Steris’s niches…